At this year’s Radiological Society of North America (RSNA) annual meeting, GE Healthcare is showcasing continued advancements in magnetic resonance imaging (MRI) technologies. In the spirit of GE MR’s Continuum strategy, the company will showcase advanced applications as well as the Signa Pioneer 3.0T, Signa Explorer and Signa Creator 1.5T MRI scanners.
A new study appearing in STEM CELLS Translational Medicine (SCTM) describes a highly efficient, protein-based method for turning fibroblasts — the most common cells in connective tissue — into cardiac progenitor cells (CPCs). The results could lead to a much-needed new source of cells for regenerating the heart. Equally exciting is that the technology also converts the fibroblasts directly to CPCs, skipping an in-between and significantly speeding up the process.
Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, a new Cedars-Sinai Heart Institute study shows. The effect was demonstrated with a drug commonly used to alleviate chest pain patients with coronary artery disease, which was found to be ineffective in patients with moderate female-pattern heart disease, but may offer some relief for sicker patients.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Preventing blood clots with drugs such as heparin has become a common practice for fighting some heart and lung conditions, and for certain surgeries. But patients who take them also need their blood to clot to heal incisions made during operations. Researchers are developing a new way to tackle this problem — by pairing snake venom with nanofibers. Their study using the therapy on rats appears in the journal ACS Biomaterials Science & Engineering.
November 12, 2015 — A pharmacist-physician collaborative effort to control blood pressure among a diverse group of ...
Computed tomography has seen rapid growth in all segments of medicine over the past two decades, and recent advances may ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
(This article was updated in June 2018) The advent of transcatheter valve repair and replacement technologies is one of ...
Imaging tests of obese children — some as young as 8 years old — showed signs of significant heart disease and heart muscle abnormalities, according to research presented at the American Heart Association’s Scientific Sessions 2015.
Two of the country’s preeminent health organizations, the American Heart Association (AHA) and the American Medical Association (AMA), announced a new nationwide initiative aimed at addressing the growing burden of high blood pressure in the United States.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new interim analysis from a long-term study evaluating the safety and effectiveness of Pradaxa (dabigatran etexilate mesylate) relative to warfarin in routine clinical practice.
Medtronic plc announced that the Medtronic Micra Transcatheter Pacing System (TPS) was successfully implanted in nearly all patients in the trial and met its safety and effectiveness endpoints with wide margins. These data, from the Medtronic Micra TPS Global Clinical Trial, were presented during a late-breaking special report session at the 2015 American Heart Association Scientific Sessions and simultaneously published in the New England Journal of Medicine.
MC3 Cardiopulmonary announced it has completed the acquisition and transfer of all assets associated with Terumo Cardiovascular's previously marketed surgical cannula line, including leading brand names like Sarns Soft-Flow Arterial Cannula. The company plans to reintroduce the cannula during the first half of 2016.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
TherOx Inc. announced it has received U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for a confirmatory safety study of a second-generation supersaturated oxygen (SSO2) therapy system. The system helps reduce infarct size after an acute myocardial infarction (AMI). This 100-patient study is being conducted to support a pre-market approval submission to the FDA.
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a randomized trial studying a new heart valve to treat aortic valve disorders. Harrisburg Hospital is the only trial site in Pennsylvania. This study represents the next wave of research with aortic valves that conform to the patient's anatomy.
November 9, 2015 — The number of angioplasty procedures classified as rarely appropriate declined sharply between 2010 ...